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Abstract  1 
To monitor the illegal use of olaquindox in animals, a monoclonal antibody-based surface 2 
plasmon resonance (SPR) biosensor method has been developed to detect 3 
3-methyl-quinoxaline-2-carboxylic acid, the marker residues of olaquindox, in swine tissues. 4 
The limit of detection was 1.4 µg kg
-1 
in swine muscle and 2.7 µg kg
-1
 in swine liver, which 5 
are lower than the EU recommended concentration (10 µg kg
-1
). The recoveries were from 6 
82% to 104.6%, with coefficients of variation of less than 12.2%. Good correlations between 7 
SPR and HPLC results (r = 0.9806, muscle; r = 0.9698, liver) and between SPR and ic-ELISA 8 
results (r = 0.9918, muscle; r = 0.9873, liver) were observed in the affected tissues, which 9 
demonstrated the reliability of the SPR method. This method would be a rapid and reliable 10 
tool for the screening of the residues of olaquindox in the edible tissues of animals. 11 
 12 
Keywords: surface plasmon resonance biosensor; 3-methyl-quinoxaline-2-carboxylic acid; 13 
olaquindox; residues; swine tissues 14 
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1. Introduction 15 
Olaquindox (OLA, Figure 1), an antibacterial growth-promoting agent in quinoxalines, 16 
was widely used in swine for the control of swine dysentery and/or bacterial enteritis in young 17 
swine, to improve feed efficiency and increase the rate of weight gain (FAO/WHO, 1990). It 18 
was also widely used in poultry and aquatic animals illegally around the world for decades 19 
(Carta, Corona, & Loriga. 2005). However, OLA was a mutagen and suspected carcinogen 20 
with photosensitive toxicity (Eberlein, Bergner, & Przybilla, 1992; Emmert, Schauder, Palm, 21 
Hallier, & Emmert, 2007; FAO/WHO, 1990), renal toxicity (FAO/WHO, 1990), genotoxicity 22 
(Chen et al., 2009; FAO/WHO, 1990; Ihsan et al., 2013; Liu et al., 2016; Yang et al., 2015; 23 
Zou et al., 2009), cytotoxicity (Huang et al., 2010; Li et al., 2016; Zou et al., 2011). Therefore, 24 
the use of OLA in food-producing animals had been banned in some countries and regions 25 
(Commission Regulation (EC) No 2788/98, 1998; FAO/WHO, 1995). In China, OLA has 26 
been approved as a feed additive for piglets weighing less than 35 kg with a withdrawal 27 
period of 35 days (Announcement No. 168, 2001). Recently, The Ministry of Agriculture 28 
(MOA) of China stipulated that OLA will be withdrawn from market before 2020 29 
(Announcement No. 2638, 2018).  30 
Although regulations exist, non-compliance remains a serious issue due to the economic 31 
benefits of OLA in food animals and the broad availability of commercial OLA worldwide. 32 
Therefore, the development of a rapid and reliable detection method for screening the residues 33 
of OLA in edible tissues of food animals is necessary. Traditionally, the use of such 34 
compounds should be controlled by the analysis of their respective metabolites in the target 35 
tissues. However, because of the lack of sufficient data on metabolism and residue depletion, 36 
the acceptable daily intake of OLA has not been recommended, the marker residue (MR) of 37 
OLA was not defined, and the maximum residue limits (MRLs) of OLA were not established 38 
(FAO/WHO, 1990). Therefore, the safety of edible tissues in the animals administered with 39 
  
 4 
OLA could not be guaranteed.  40 
In 1995, 3-methylquinoxaline-2-carboxylic acid (MQCA) was tentatively recommended 41 
as the MR of OLA by FAO/WHO (1995) for the control of OLA residues in the edible tissues 42 
of animals treated with OLA. In 2007, European Reference Laboratory proposed for MQCA 43 
in meat a recommended concentration (RC) of 10 µg kg
−1
 for analytical method (CRL 44 
Guidance Paper, 2007). In China, the MRLs of MQCA, which is in keeping with the report of 45 
JECFA, is set at 50 µg kg
−1 
in swine liver and 4 µg kg
−1
 in swine muscle (Announcement No. 46 
235, 2002; FAO/WHO, 1995). 47 
During the past decades, several physicochemical methods, including high performance 48 
liquid chromatography (HPLC) ( Wu et al., 2007; Zhang, Zheng, Zhang, Chen, & Mei, 2011) 49 
and liquid chromatography tandem mass spectrometry (LC-MS/MS) (Boison, Lee, & Gedir, 50 
2009; Hutchinson, Young, & Kennedy, 2005; Merou, Kaklamanos, & Theodoridis, 2012), 51 
have been developed for olaquindox and its marker residue MQCA. However, due to the high 52 
cost and the need for skilled scientists, these physicochemical methods are more suitable for 53 
confirmatory analysis than screening methods. As an alternative, an antibody-based rapid and 54 
sensitive indirect competitive enzyme-linked immunosorbent assay screening method 55 
(ic-ELISA) for detecting MQCA residues had also been published (Cheng et al., 2013; Jiang, 56 
Beier, Wang, Wu, & Shen, 2013; Yue et al., 2009; Zhang et al., 2015). Although these 57 
methods are available, they are acknowledged to be tedious with time-consuming steps such 58 
as washing, separation of bound and free antigen, and a lengthy incubation time.  59 
The emergence of biosensor-based immunological assays, such as the optical based 60 
surface plasmon resonance (SPR) detection which is a label-free technique for the sensitive 61 
real-time monitoring of molecular interactions, in the field of food safety testing offers 62 
prominent advantages such as high sensitivity, low limit of detection, specificity and 63 
robustness (Campbell et al., 2009). In the past few years, the SPR method has been used 64 
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successfully in the field of food safety detection (Caldow et al., 2005; Devlin et al., 2014; 65 
Hirakawa et al., 2018; Olaru, Bala, Jaffrezic-Renault, & Aboul-Enein, 2015; Pan, Li, Wang, 66 
Sheng, & Wang, 2017; Yuan, Deng, Lauren, Aguilar, & Wu, 2009). Nevertheless, to our best 67 
knowledge, no SPR biosensor method has been developed for detection of MQCA residues.  68 
Therefore, the aim of the present study was to develop and validate an SPR biosensor 69 
method for the analysis of MQCA residues in edible animal tissue samples without the 70 
necessity of a complicated sample preparation procedure.  71 
2. Materials and Methods 72 
2.1 Chemicals and reagents 73 
Ovalbumin (OVA), dicyclohexylcarbodiimide (DCC), N-hydroxysuccinimide (NHS), 74 
N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), and ethanolamine 75 
hydrochloride (1 M, pH 8.5) were purchased from Sigma-Aldrich (St. Louis, MO, USA). A 76 
carboxymethylated dextran CM5 chip was purchased from Biacore AB (Uppsala, Sweden). 77 
HBS-EP buffer (0.01 M HEPES, 0.15 M NaCl, 3 mM EDTA and 0.005% Surfactant P20, pH 78 
7.4) were also purchased from Biacore AB (Uppsala, Sweden). Purified and deionized water 79 
was obtained from Millipore reverse osmosis and milli-Q polishing systems. The primary 80 
stock solution at 1 mg mL
-1
 was prepared by dissolving the compound in the purified and 81 
deionized water (milli-Q). Serial dilutions were prepared by diluting the primary stock 82 
solution in HBS-EP buffer. All other chemicals were also purchased from Sigma-Aldrich (St. 83 
Louis, MO, USA) and were of analytical grade.  84 
The standard analytes MQCA, NH2MQCA, and NH2MQCA-OVA (shown in Figure 1) 85 
and the anti-MQCA monoclonal antibody 5B10 (mAb 5B10, 1 mg mL
-1
) were supplied by the 86 
Institute of Veterinary Pharmaceuticals, Huazhong Agricultural University (Wuhan, China), in 87 
which their structures and/or their characteristics had been guaranteed (Zhang et al., 2015). 88 
Briefly, the standard analyte MQCA was purchased from the Institute of Veterinary Drug 89 
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Control (Beijing, China). The hapten NH2MQCA was identified by nuclear magnetic 90 
resonance (NMR, Bruker-400 spectrometers, Bruker BioSpin, Switzerland) and ion trap and 91 
time-of-flight mass spectrometers coupled with a HPLC system (LC/MS-ITTOF, Shimadzu, 92 
Kyoto, Japan), respectively. MS m/z calculated for C10H9N3O2 [M+H]
+
 204.0768, found 93 
204.0763. H
1
 NMR (DMSO-d6) δH: 2.73 (s, 3H, C3-CH3), 6.84, 7.23, 7.39 (each 1H, Ar-H), 94 
4.60 (br, 2H, -NH2), 12.0~13.0 (br, 1H, -COOH). The synthesized coating conjugate 95 
NH2MQCA-OVA was characterized by 8453 UV-Visible spectrophotometer (Aglient 8453, 96 
USA), which the estimated incorporation rates of conjugates is 9.7. The obtained specific 97 




 for MQCA and did not 98 
exhibit measurable cross-reactivity (CR) with other quinoxalines and their analogues (CR < 99 
0.1%) such as OLA, quinocetone, mequindox, cyadox, carbadox, quinoxaline-2-carboxylic 100 
acid, desoxymequindox, desoxyquinocetone, and desoxyolaquindox (Zhang et al., 2015). 101 
2.2. Immobilization of ligand on CM5 chip 102 
As shown in Figure 1, the NH2MQCA contains a standard amino group. Therefore, it is 103 
immobilized covalently on a CM5 chip by an amine coupling procedure in two steps 104 
according to Campbell’s procedure (Campbell et al., 2009) with modification. Briefly, the 105 
chip was allowed to equilibrate to room temperature, and a continuous flow of HBS-EP buffer 106 
passing over the sensor surface at a flow rate of 5 μL min
−1
 was maintained. OVA, as a ligand, 107 
was first immobilized on the CM5 chip surface. In this procedure, the carboxyl groups on the 108 
CM5 chip surface were activated by 50 µL of a 1:1 (v/v) mixture of 0.4 M 109 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and 0.1 M 110 
N-hydroxysuccinimide (NHS) at a flow rate of 7 μL min
-1
 for 7 min. OVA (10 mg ml
-1
, pH 111 
4.0, 10 mM sodium acetate (NaAc) buffer) was run onto the activated chip at a flow rate of 6 112 
μL min
-1
 for 15 min, with OVA immobilized on the CM5 chip. The remaining un-reacted 113 
groups on the sensor surface were deactivated by the injection of ethanolamine-HCl (1 M, pH 114 
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8.5) at a flow rate of 5 μL min
-1
 for 7 min. After the surface was washed with 10 mM sodium 115 
hydroxide (NaOH) at a flow rate of 20 μL min
-1
 for 1 min (this step was repeated 3 times), 10 116 
mM glycine-HCl (pH 3.0) was used to regenerate the chip at a rate of 20 μL min
-1
 for 1 min. 117 
Second, the same procedure was used to immobilize the ligand NH2MQCA (200 μg mL
-1
) on 118 
the surface of the chip and/or on the carrier protein OVA that had been immobilized on the 119 
surface of the chip. Finally, the chip surface was washed with deionized water, then dried 120 
under a stream of nitrogen gas, and stored in a desiccated container (4 °C) 121 
2.3 Optimization of the SPR-biosensor analytical conditions 122 
The optical surface plasmon resonance (SPR) biosensor used was a Biacore 3000 (GE 123 
Healthcare, Sweden) with Biacore
®
 Q control software version 3.0.1, which was used for the 124 
sensorgram and data analysis. Because the BIACORE Q Control Software offered a suitable 125 
means of developing and running projects automatically under controlled conditions, only 126 
limited parameters were necessary for the investigation of the development of the Biacore 127 
3000 biosensor assay, including binder dilution, ratio of binder to standard, injection volume, 128 
contact time, and the regeneration solution. In this project, studies were conducted at 25 °C. 129 
Briefly, mAb 5B10 (1 mg mL
-1
) was diluted in HBS-EP buffer (1:100, 1:200, 1:500, 1:800, 130 
1:1000) and was tested to determine the optimal concentration of antibody dilution for the 131 
inhibition assay in the biosensor (200-300 resonance units (RU)). To test the optimal ratio of 132 
binder to standard, injection volume, and contact time, the standard solution was transferred 133 
into the wells of a U-bottomed microtitre plate (Greiner Bio One, Gloucestershire, UK) and 134 
mixed with antibody solution in different ratios (3:1, 2:1, 1:1, 1:2, 1:3, v/v) by the 135 
autosampler via the control software. Then, the mixtures were injected over the sensor chip 136 
surface at different flow rates (15, 20, 25 µL min
-1
) for different times (150 s, 240 s, and 300 137 
s). In addition, chip surface regeneration was performed to reuse the sensor chip. 138 
Regeneration removes bound analyte at the end of each cycle by injecting a pH buffer over 139 
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the surface but leaves the ligand attached to the chip surface so another sample can be 140 
analysed. To test for the optimal regeneration solution, different concentrations of NaOH 141 
solution (5 mM, 10 mM, 20 mM) and glycine-HCl (pH 3.0) solution (5 mM, 10 mM, 20 mM) 142 
were used. 143 
2.4. Preparation of standards for SPR analysis 144 
To compare the calibration curves prepared from extracts of the different tissue matrices 145 
following extraction with the extracts prepared in HBS–EP buffer, three standard curves were 146 
prepared. The standard dose response curve was obtained according to the RU values and 147 
concentrations of standards. The standard curves were fitted using the following equation: 148 
y=(A-D)/[1+(x/C)^B]+D. where A and D are the responses at high and low asymptotes of the 149 
curve, respectively, C is the concentration of the targets resulting in 50% inhibition, B is the 150 
slope at the inflection point of the sigmoid, and X is the calibration concentration. 151 
For standard curve A, a calibration curve consisting of five concentrations was 152 
constructed by diluting the MQCA stock standard (1000 μg mL
-1
) in HBS-EP buffer, ranging 153 
from 0 to 100 ng mL
-1
 (0, 6.25, 12.5, 25, 50, 100 ng mL
-1
).  154 
To prepare standard curve B, known negative tissue was extracted as described for 155 
sample preparation, and aliquots (1 mL) were spiked with MQCA stock standard (1000 μg 156 
mL
-1
) to provide 5 calibration standards (0, 6.25, 12.5, 25, 50, 100 ng mL
-1
) for the calibration 157 
curve. 158 
To prepare standard curve C, known negative tissue was spiked with known amounts of 159 
MQCA at 0 μg kg
-1
, 6.25 μg kg
-1
, 12.5 μg kg
-1
, 25 μg kg
-1
, 50 μg kg
-1
, and 100 μg kg
-1
 and 160 
then extracted as described for sample preparation to obtain 5 calibration standards for the 161 
calibration curve. 162 
2.5 Sample preparation 163 
 Samples such as swine muscle and liver were minced and homogenized. Each 164 
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homogenized sample (2 g) was weighed into a 50-mL polypropylene centrifuge tube. Ethyl 165 
acetate (6 mL) and 3.0 mL of 1.25 M HCl were added, and the mixture was vortex-mixed for 166 
3 min and then centrifuged for 5 min at 4000 × g. The supernatant (4 mL) was transferred into 167 
another 50-mL polypropylene centrifuge tube, 4 mL of saturated NaCl solution was added, 168 
and the solution was mixed for 1 min. After standing for 5 min, 3 mL of ethyl acetate was 169 
dried using nitrogen gas at 50 °C. Then, the muscle sample residue was re-dissolved with 1 170 
mL of HSB-EP buffer, and the liver sample residue was re-dissolved with 3 mL of HSB-EP 171 
buffer and washed with 1 mL of hexane. After being centrifuged for 5 min at 4000 × g, the 172 
water phase was filtered with a 0.45-μm filter and was then used in the SPR. 173 
2.6 Validation of the SPR 174 
Because China is the world's largest OLA consumption country, accounting for more 175 
than 80% of OLA consumption in the world, the document [2005] No. 17 issued by the 176 
Ministry of Agriculture veterinary bureau (2005) was therefore selected for the validation of 177 
the SPR method. According to this document, some parameters including limit of 178 
determination (LOD), accuracy and precision were determined to validate the SPR method 179 
based on the optimized standard curve and the sample preparation procedure. Briefly, 20 180 
known negative swine muscle and liver samples, purchased from a local supermarket (Tesco, 181 
Marks & Spencer, Sainsbury’s) and previously been proven by HPLC analysis (Wu et al., 182 
2007) to be free of OLA and its MR MQCA, were analysed by the SPR method. The 183 
determination of the LOD was based on 20 blank samples accepting no false positive rates, 184 
with an average + 3 standard deviation (SD). The accuracy and precision of the method were 185 
expressed by the recovery and coefficient of variation (CV), respectively. The recovery 186 
(percentage) of MQCA was established using five spiked duplicate blanks at levels of ½ MRL 187 
(2 μg kg
-1 
in muscle and 25 μg kg
-1 
in liver), MRL (4 μg kg
-1 
in muscle and 50 μg kg
-1 





in muscle and 100 μg kg
-1 
in liver) obtained from three different 189 
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analyses and was calculated using the following equation: (concentration 190 
measured/concentration spiked) × 100. CVs were determined by analysing samples spiked 191 
with MQCA at the same levels of above from five different analyses. Each concentration level 192 
was tested three times in a time span of 2 months. 193 
2.7 Comparison of the SPR biosensor with ic-ELISA and HPLC 194 
To test the detection capability of the developed SPR biosensor, seven pig samples were 195 
supplied by the National Reference Laboratory of Veterinary Drug Residues (Huazhong 196 
Agricultural University, HZAU) and MOA Key Laboratory for the Detection of Veterinary 197 
Drug Residues in Foods (Wuhan, China). In addition, thirty-five unknown samples, including 198 
seventeen swine muscle samples and eighteen swine liver samples that were collected from 199 
Northern Ireland by Chen in 2012 were also prepared. These samples were analysed by the 200 
current SPR biosensor, the ic-ELISA method and the HPLC analysis.  201 
The ic-ELISA method was performed according to the publication (Zhang et al., 2015) 202 
that was developed using the same mAb 5B10. The limits of detection ranged from 1.9 µg 203 
kg
-1
 to 4.3 µg kg
-1
. The recoveries ranged from 74.2% to 98.9% with a maximum of 17.3% 204 
for the CV. The HPLC analyses were performed according to the procedure of Wu et al. (2007) 205 
with modifications. Briefly, all HPLC analyses were performed using a Waters HPLC system, 206 
comprising a 2695 ternary pump and 2487 UV detection. An Eclipse XDB-C18 (250 mm, 4.6 207 
mm I.D.) (Agilent Technology, USA) HPLC column was used for sample separation. The 208 
temperature of the HPLC column was set at 30 °C. The mobile phase was acetonitrile/water 209 
containing 1% acetic acid (18:82 v/v for the plasma, muscle, liver, and fat samples; 20:80 v/v 210 
for the kidney samples). The mobile phase was pumped at a flow rate of 1.0 mL min
-1
. The 211 
spectra of all the samples were obtained from detection at the wavelength of 320 nm. 212 
3. Results and Discussion 213 
3.1 SPR analysis format design 214 
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One of the most challenging steps for an SPR-based assay is the design of the analysis 215 
format. In this study, two formats (shown in Figure 2) were designed to perform the SPR 216 
analysis. Format A used NH2MQCA as the ligand which was immobilized on the CM5 chip 217 
surface using an amine coupling method (EDC/NHS was used to activate the 218 
carboxymethylated CM5 chip surface before the NH2MQCA was immobilized). Format B 219 
was similar to format A except in using the carrier protein OVA as a linker. For format A, 220 
obtaining an obvious change of RU value was easily accomplished. However, in some 221 
instances, the small molecular NH2MQCA directly immobilized on the CM5 chip surface was 222 
unstable, resulting in unacceptably low levels of immobilised ligand. For all these reasons, 223 
format B was selected to perform the SPR analysis. 224 
3.2 The optimization of the SPR-biosensor analytical conditions and procedure 225 
An antibody dilution of 1/500 (v/v) was found to give satisfactory results under the assay 226 
conditions. The samples (calibrants and spiked samples) were transferred into the wells of a 227 
U-bottomed microtitre plate and mixed with antibody solution at a ratio of 1:1 (v/v) by the 228 
autosampler via the control software and injected for 240 s over the sensor chip surface at a 229 
rate of 20 µL min
-1
. The chip surface was regenerated between cycles using 10 mM sodium 230 
hydroxide for 60 s at a flow rate of 20 µL min
-1
 and then using 10 mM glycine-HCl (pH 3.0) 231 
for 60 s at a flow rate of 20 µL min
-1
. The binding of the antibody to the chip surface was 232 
measured as the change in SPR signal between two reported points before (10 s) and after (20 233 
s) each injection. A competitive immunoassay assay format (format B that was described in 234 
section 3.1) was used to detect inhibition of antibody binding to the chip surface. The SPR 235 
signal was expressed in arbitrary RUs. In this format, as the MQCA concentration increases, 236 
more anti-MQCA antibody is bound resulting in fewer antibodies binding to the ligand on the 237 
sensor surface. This inhibition of antibody binding to the ligand indicates that the RU readout 238 




The efficiency of immobilization was tested by assessing the Rmax value. Rmax provides 241 
useful information on how effective the immobilized ligand is, in contact with its binding 242 
partner. Rmax is the maximum binding capacity of the NH2MQCA (ligand) for the 243 
anti-MQCA antibody, as measured in RUs. In this study, the Rmax that was obtained was 244 
1084.5 RUs achieved by injecting a high concentration (1/10) of anti-MQCA monoclonal 245 
antibody (5B10) over the chip surface for an extended time (15 min).  246 
3.3 Standard curves 247 
In general, matrix matched standard curves are used to reduce potential matrix effects in 248 
the analytical procedure (Diblikova, Cooper, Kennedy, & Franek, 2005). However, the 249 
preparation of matrix-matched standards from blank samples prior to analysis might be less 250 
favourable (when multiple sample tissues are involved) for incorporation into a commercial 251 
kit. In order to adapt the test to be commercially viable, three different standard curves were 252 
compared in this study to determine if a buffer matrix would suffice. As shown in Figure 3A, 253 
the HBS–EP buffer-based standard curve (standard curve A) and the matrix-based standard 254 
curves (standard curve B and standard curve C) were obtained. Upon comparing these 255 
standard curves, good correlations between standard curve A and standard curve B (Figure 3B, 256 
r = 0.9968) and between the standard curve A and standard curve C (Figure 3C, r = 0.9922) 257 
were observed. Therefore, standard curve A was selected for this study. Under these 258 
optimized conditions, the sensitivity (IC50) of the SPR assay was 12.9 ng mL
-1
.  259 
3.4 SPR method validation and compared with ic-ELISA and HPLC analysis 260 
The sample preparation procedures play an important role in the development of the SPR 261 
method. In this study, ethyl acetate and HCl were used successfully to extract MQCA 262 
compounds from swine muscle and liver samples. Hexane was used to eliminate most of the 263 
fat during the extraction procedure. Then, 0.45-µm syringe filters (Whatman, GE Healthcare 264 
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Life Sciences) were used to remove particulate matter from the extract. This approach is 265 
consistent with the study of Zhang et al. (2015) except for the use of the filter.  266 
As shown in Table 1, based on the results from twenty different blank samples, the 267 
LODs of the method were 1.4 µg kg
-1
 and 2.7 µg kg
-1
 in swine muscle and swine liver, 268 
respectively, which are lower than the RC (10 µg kg
-1
) by EU. As described in the 269 
introduction, OLA is still used in China and the MRLs of the MR which defined as MQCA 270 
had been set at 50 µg kg
−1 
in swine liver and 4 µg kg
−1
 in swine muscle. Therefore, three 271 
concentration levels, including ½ MRL, MRL, and 2MRL were selected to evaluate the 272 
accuracy and precision of the SRP method in this study. As shown in Table 1, the recoveries 273 
of swine muscle and swine liver samples spiked with MQCA at the above three concentration 274 
levels were in the range of 82% to 104.6%, with CVs less than 12.2%. These data indicated 275 
that the SPR method fill the need for the rapid screening determination of MQCA residues in 276 
swine tissues. 277 
As shown in Figure 4, the calculated concentrations from the standard curve with each 278 
technique (ic-ELISA, HPLC, SPR) were compared. Good correlations (r = 0.9698, SPR and 279 
HPLC; r = 0.9873, SPR and ic-ELISA) were observed in the swine liver tissues (Figure 4A). 280 
Similarly, good correlations (r = 0.9806, SPR and HPLC; r = 0.9918, SPR and ic-ELISA) 281 
were also observed in the swine muscle tissues (Figure 4B). For the thirty-eight unknown 282 
samples, no MQCA could be detected by SPR, ELISA, or HPLC analysis. These data 283 
suggested that the SPR method is reliable. 284 
In 2015, an ic-ELISA method was developed to determine the residue of MQCA in 285 
edible animal tissues using the same mAb 5B10 (Zhang et al., 2015). Comparison between 286 
the SPR method and the ic-ELISA method was therefore reasonable. As shown in Table 2, 287 
compared with the ic-ELISA method, the SPR method is label-free, more sensitive (IC50, 12.9 288 
ng mL
-1
 in SPR ＜17.7 ng mL-1 in ic-ELISA), more precise (CVs, 12.2% in SPR ＜ 17.3% 289 
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in ic-ELISA).  290 
4. Conclusions 291 
In this study, a mAb-based SPR method for monitoring MQCA in swine muscle and 292 
swine liver was developed with label-free, high sensitivity (IC50, 12.9 ng mL
-1
, LOD, 1.4 µg 293 
kg
-1
 in swine muscle and 2.7 µg kg
-1
 in swine liver), good accuracy (recovery ranged from 294 
82% to 104.6%) and precision (CVs, 12.2%). Obviously, the LODs are lower than both the 295 
EU RC (10 µg kg
-1
) and the Chinese MRL (50 µg kg
−1 
in swine liver and 4 µg kg
−1
 in swine 296 
muscle). The HBS–EP buffer-based standard curve make it more convenient to incorporate 297 
into the kit format that can be fully transferable to other laboratories. In summary, the SPR 298 
method for MQCA, although no longer in its infancy as a new technology, offers the ability 299 
for rapid and reliable detection of trace amounts of MQCA, the marker residues of OLA, in 300 
food of animal origin and its implementation will enable timely corrective actions to be taken 301 
to prevent unsafe food from entering into the food supply chain.  302 
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Figure legends 434 
Figure 1 The chemical structure of olaquindox and its metabolite 435 
Figure 2 The design of the format of the SPR analysis 436 
Figure 3 Standard curves for the quantification of MCQA. (A) three standard curves 437 
based on different matrices.  standard curve A, the HBS–EP buffer matrix;  standard 438 
curve B, the blank extract-based matrix;  standard curve C, the spiked extract based matrix 439 
(B) comparison of standard curves A and B, y = 0.9296x + 12.066, r = 0.9968; (C), 440 
comparison of standard curves A and C, y = 0.8979x + 27.753, r = 0.9922 441 
 Figure 4 Comparison with SPR, ic-ELISA and HPLC analysis in edible swine tissues. 442 
(A) comparison with SPR, ic-ELISA and HPLC analysis in swine liver samples; (B) 443 




Table Titles 446 
Table 1 The LOD, recoveries and coefficients of variation (CVs) of the SPR 447 





Table 1 The LOD, recoveries and coefficients of variation (CVs) of the SPR 451 












swine muscle 1.4 2 104.6 ± 12.0 11.5 
  4 89.9 ± 9.8 10.9 
  8 82.0 ± 6.7 8.2 
swine liver 2.7 25 85.8 ± 10.5 12.2 
  50 87.1 ± 7.7 8.8 





Table 2 Comparison between the SPR method and the ic-ELISA method 454 
items SPR method  ic-ELISA method
a
 
antibody Monoclonal antibody 5B10  Monoclonal antibody 5B10 
IC50 (ng mL
-1
) 12.9  17.7 
LOD (µg kg
-1
) 1.4 µg kg
-1
 in swine muscle 
2.7 µg kg
-1
 in swine liver 
 1.9 µg kg
-1
 in swine muscle 
4.3 µg kg
-1
 in swine liver 
recovery from 82% to 104.6%  from 74.2% to 98.9% 
coefficient of 
variation 
＜12.2%  ＜17.3% 
the sample 
preparation 
ethyl acetate, HCl, saturated 
NaCl solution, HSB-EP buffer, 
hexane, 0.45-μm filter  
 ethyl acetate, HCl 
saturation NaCl solution, 
phosphate buffer, hexane 
detection time (does 





  90 min kit
-1




regeneration yes (at least 200 cycles)  no 
label or not no  yes, horseradish peroxidase 
labeled is necessary 
Note: 
a
















A.  465 
B.  466 
 467 
C.  468 
Figure 3  469 
470 
The response from standard curve A (RU) 
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Figure 4 476 
477 
The calculated concentrations from SPR (µg kg−1) 












































































Research highlights 480 
  481 
 A new SPR method for the determination of MQCA had been reported.  482 
 The developed SPR method is the first report for MQCA in animal tissues. 483 
 The SPR method can serve as an effective screening tool in any routine laboratory. 484 
 485 
